ID   S22A5_RAT               Reviewed;         557 AA.
AC   O70594; Q9QWL0;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   29-MAY-2024, entry version 167.
DE   RecName: Full=Organic cation/carnitine transporter 2;
DE   AltName: Full=CT1;
DE   AltName: Full=High-affinity sodium-dependent carnitine cotransporter;
DE   AltName: Full=Solute carrier family 22 member 5;
DE   AltName: Full=UST2r;
GN   Name=Slc22a5; Synonyms=Octn2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=9541011; DOI=10.1016/s0014-5793(98)00203-8;
RA   Schoemig E., Spitzenberger F., Engelhardt M., Martel F., Oerding N.,
RA   Gruendemann D.;
RT   "Molecular cloning and characterization of two novel transport proteins
RT   from rat kidney.";
RL   FEBS Lett. 425:79-86(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Intestine;
RX   PubMed=9792817; DOI=10.1006/bbrc.1998.9521;
RA   Sekine T., Kusuhara H., Utsunomiya-Tate N., Tsuda M., Sugiyama Y.,
RA   Kanai Y., Endou H.;
RT   "Molecular cloning and characterization of high-affinity carnitine
RT   transporter from rat intestine.";
RL   Biochem. Biophys. Res. Commun. 251:586-591(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, TRANSPORTER
RP   ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10454528;
RA   Wu X., Huang W., Prasad P.D., Seth P., Rajan D.P., Leibach F.H., Chen J.,
RA   Conway S.J., Ganapathy V.;
RT   "Functional characteristics and tissue distribution pattern of organic
RT   cation transporter 2 (OCTN2), an organic cation/carnitine transporter.";
RL   J. Pharmacol. Exp. Ther. 290:1482-1492(1999).
RN   [4]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=17616214; DOI=10.1021/mp070023l;
RA   Maeda T., Goto A., Kobayashi D., Tamai I.;
RT   "Transport of organic cations across the blood-testis barrier.";
RL   Mol. Pharm. 4:600-607(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Sodium-ion dependent, high affinity carnitine transporter.
CC       Involved in the active cellular uptake of carnitine. Transports one
CC       sodium ion with one molecule of carnitine. Also transports organic
CC       cations such as tetraethylammonium (TEA) without the involvement of
CC       sodium. Also relative uptake activity ratio of carnitine to TEA is
CC       11.3. May also contribute to regulate the transport of organic
CC       compounds in testis across the blood-testis-barrier (Probable).
CC       {ECO:0000269|PubMed:10454528, ECO:0000305|PubMed:17616214}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-carnitine(out) + Na(+)(out) = (R)-carnitine(in) +
CC         Na(+)(in); Xref=Rhea:RHEA:72091, ChEBI:CHEBI:16347,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:10454528};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(out) + O-acetyl-(R)-carnitine(out) = Na(+)(in) + O-
CC         acetyl-(R)-carnitine(in); Xref=Rhea:RHEA:72099, ChEBI:CHEBI:29101,
CC         ChEBI:CHEBI:57589; Evidence={ECO:0000269|PubMed:10454528};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(out) + O-propanoyl-(R)-carnitine(out) = Na(+)(in) + O-
CC         propanoyl-(R)-carnitine(in); Xref=Rhea:RHEA:72103, ChEBI:CHEBI:29101,
CC         ChEBI:CHEBI:53210; Evidence={ECO:0000269|PubMed:10454528};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycine betaine(out) + Na(+)(out) = glycine betaine(in) +
CC         Na(+)(in); Xref=Rhea:RHEA:72115, ChEBI:CHEBI:17750,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000250|UniProtKB:O76082};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-carnitine(in) + glycine betaine(out) = (R)-carnitine(out)
CC         + glycine betaine(in); Xref=Rhea:RHEA:72119, ChEBI:CHEBI:16347,
CC         ChEBI:CHEBI:17750; Evidence={ECO:0000250|UniProtKB:O76082};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(out) + O-butanoyl-(R)-carnitine(out) = Na(+)(in) + O-
CC         butanoyl-(R)-carnitine(in); Xref=Rhea:RHEA:72123, ChEBI:CHEBI:21949,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000250|UniProtKB:O76082};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-carnitine(out) + Na(+)(out) = (S)-carnitine(in) +
CC         Na(+)(in); Xref=Rhea:RHEA:72095, ChEBI:CHEBI:11060,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000250|UniProtKB:O76082};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(out) + O-acyl-(R)-carnitine(out) = Na(+)(in) + O-acyl-
CC         (R)-carnitine(in); Xref=Rhea:RHEA:72107, ChEBI:CHEBI:29101,
CC         ChEBI:CHEBI:75659; Evidence={ECO:0000250|UniProtKB:O76082};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine(out) +
CC         Na(+)(out) = L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine(in)
CC         + Na(+)(in); Xref=Rhea:RHEA:72111, ChEBI:CHEBI:29101,
CC         ChEBI:CHEBI:191852; Evidence={ECO:0000250|UniProtKB:O76082};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N,N-dimethylglycine(out) + Na(+)(out) = N,N-
CC         dimethylglycine(in) + Na(+)(in); Xref=Rhea:RHEA:76591,
CC         ChEBI:CHEBI:29101, ChEBI:CHEBI:58251;
CC         Evidence={ECO:0000250|UniProtKB:O76082};
CC   -!- ACTIVITY REGULATION: Inhibited by emetine, quinidine and verapamil. The
CC       IC(50) of emetine is 4.2 uM. Not inhibited by valproic acid. Transport
CC       of (R)-carnitine is stimulated by cholesterol in the plasma membrane.
CC       {ECO:0000250|UniProtKB:O76082}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=63 uM for tetraethylammonium (at pH 7.5)
CC         {ECO:0000269|PubMed:10454528};
CC         KM=14.8 uM for carnitine (at pH 7.5 adn 140 mM NaCl)
CC         {ECO:0000269|PubMed:10454528};
CC   -!- SUBUNIT: Interacts with PDZK1. {ECO:0000250|UniProtKB:Q9Z0E8}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O76082};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:O76082}. Apical cell
CC       membrane {ECO:0000250|UniProtKB:O76082}; Multi-pass membrane protein
CC       {ECO:0000255}. Basal cell membrane {ECO:0000250|UniProtKB:O76082};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in the proximal and distal tubules and in
CC       the glomeruli in the kidney, in the myocardium, valves, and arterioles
CC       in the heart, in the labyrinthine layer of the placenta, and in the
CC       cortex, hippocampus, and cerebellum in the brain. Expressed in Sertoli
CC       cells in testis (PubMed:17616214). {ECO:0000269|PubMed:10454528,
CC       ECO:0000269|PubMed:17616214}.
CC   -!- SIMILARITY: Belongs to the major facilitator (TC 2.A.1) superfamily.
CC       Organic cation transporter (TC 2.A.1.19) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ001933; CAA05106.1; -; mRNA.
DR   EMBL; AB017260; BAA34399.1; -; mRNA.
DR   EMBL; AF110416; AAD54059.1; -; mRNA.
DR   PIR; JE0346; JE0346.
DR   RefSeq; NP_062142.1; NM_019269.1.
DR   AlphaFoldDB; O70594; -.
DR   SMR; O70594; -.
DR   IntAct; O70594; 4.
DR   STRING; 10116.ENSRNOP00000069462; -.
DR   BindingDB; O70594; -.
DR   ChEMBL; CHEMBL1075238; -.
DR   GlyCosmos; O70594; 3 sites, No reported glycans.
DR   GlyGen; O70594; 3 sites.
DR   iPTMnet; O70594; -.
DR   PhosphoSitePlus; O70594; -.
DR   PaxDb; 10116-ENSRNOP00000011340; -.
DR   Ensembl; ENSRNOT00000011340.5; ENSRNOP00000011340.4; ENSRNOG00000008432.8.
DR   Ensembl; ENSRNOT00055043532; ENSRNOP00055035525; ENSRNOG00055025236.
DR   Ensembl; ENSRNOT00060040853; ENSRNOP00060033791; ENSRNOG00060023559.
DR   Ensembl; ENSRNOT00065008386; ENSRNOP00065005905; ENSRNOG00065005626.
DR   GeneID; 29726; -.
DR   KEGG; rno:29726; -.
DR   UCSC; RGD:3702; rat.
DR   AGR; RGD:3702; -.
DR   CTD; 6584; -.
DR   RGD; 3702; Slc22a5.
DR   eggNOG; KOG0255; Eukaryota.
DR   GeneTree; ENSGT00940000154155; -.
DR   InParanoid; O70594; -.
DR   OMA; WRLVFVW; -.
DR   OrthoDB; 1448128at2759; -.
DR   PhylomeDB; O70594; -.
DR   TreeFam; TF315847; -.
DR   Reactome; R-RNO-200425; Carnitine metabolism.
DR   Reactome; R-RNO-549127; Organic cation transport.
DR   PRO; PR:O70594; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000008432; Expressed in adult mammalian kidney and 18 other cell types or tissues.
DR   ExpressionAtlas; O70594; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0031526; C:brush border membrane; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:ARUK-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:1901235; F:(R)-carnitine transmembrane transporter activity; IMP:ARUK-UCL.
DR   GO; GO:0015199; F:amino-acid betaine transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0015226; F:carnitine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; ISO:RGD.
DR   GO; GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:1902270; P:(R)-carnitine transmembrane transport; IDA:UniProtKB.
DR   GO; GO:1900749; P:(R)-carnitine transport; ISO:RGD.
DR   GO; GO:0007512; P:adult heart development; ISO:RGD.
DR   GO; GO:0009437; P:carnitine metabolic process; ISO:RGD.
DR   GO; GO:0015879; P:carnitine transport; IDA:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0007005; P:mitochondrion organization; ISO:RGD.
DR   GO; GO:0060731; P:positive regulation of intestinal epithelial structure maintenance; ISO:RGD.
DR   GO; GO:0015697; P:quaternary ammonium group transport; IDA:RGD.
DR   GO; GO:0048608; P:reproductive structure development; ISO:RGD.
DR   GO; GO:0034612; P:response to tumor necrosis factor; ISS:UniProtKB.
DR   GO; GO:0034341; P:response to type II interferon; ISS:UniProtKB.
DR   GO; GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW.
DR   GO; GO:0070715; P:sodium-dependent organic cation transport; ISO:RGD.
DR   GO; GO:0150104; P:transport across blood-brain barrier; ISO:RGD.
DR   CDD; cd17376; MFS_SLC22A4_5_OCTN1_2; 1.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005828; MFS_sugar_transport-like.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR004749; Orgcat_transp/SVOP.
DR   InterPro; IPR045915; S22A4/5.
DR   InterPro; IPR005829; Sugar_transporter_CS.
DR   NCBIfam; TIGR00898; 2A0119; 1.
DR   PANTHER; PTHR24064; SOLUTE CARRIER FAMILY 22 MEMBER; 1.
DR   PANTHER; PTHR24064:SF283; SOLUTE CARRIER FAMILY 22 MEMBER 5; 1.
DR   Pfam; PF00083; Sugar_tr; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   PROSITE; PS50850; MFS; 1.
DR   PROSITE; PS00216; SUGAR_TRANSPORT_1; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Glycoprotein; Ion transport; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..557
FT                   /note="Organic cation/carnitine transporter 2"
FT                   /id="PRO_0000220502"
FT   TOPO_DOM        1..20
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        21..41
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        42..142
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        143..163
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        164..172
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        173..193
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        194..197
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        198..218
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        219..232
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        233..253
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        254..257
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        258..278
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        279..341
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        342..362
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        363..373
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        374..394
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        395..406
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        407..427
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        428..430
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        431..451
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        452..462
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        463..483
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        484..488
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        489..509
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        510..557
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          537..557
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         218..225
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         486
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O76082"
FT   MOD_RES         548
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         550
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O76082"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        64
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        91
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        275
FT                   /note="W -> G (in Ref. 2; BAA34399)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   557 AA;  62567 MW;  172472E7B0A5F043 CRC64;
     MRDYDEVTAF LGEWGPFQRL IFFLLSASII PNGFNGMSIV FLAGTPEHRC LVPHTVNLSS
     AWRNHSIPLE TKDGRQVPQS CRRYRLATIA NFSALGLEPG RDVDLEQLEQ ENCLDGWEYN
     KDVFLSTIVT EWDLVCKDDW KAPLTTSLFF VGVLMGSFIS GQLSDRFGRK NVLFLTMGMQ
     TGFSFLQLFS VNFEMFTVLF VLVGMGQISN YVAAFVLGTE ILSKSIRIIF ATLGVCIFYA
     FGFMVLPLFA YFIRDWRMLL LALTVPGVLC GALWWFIPES PRWLISQGRV KEAEVIIRKA
     AKFNGIVAPS TIFDPSELQD LNSKKPQSHH IYDLVRTRNI RIITIMSIIL WLTISVGYFG
     LSLDTPNLHG DIYVNCFLLA AVEVPAYVLA WLLLQHLPRR YSISAALFLG GSVLLFIQLV
     PSELFYLSTA LVMVGKFGIT SAYSMVYVYT AELYPTVVRN MGVGVSSTAS RLGSILSPYF
     VYLGAYDRFL PYILMGSLTI LTAILTLFFP ESFGAPLPDT IDQMLRVKGI KQWQIQSQTR
     TQKDGGESPT VLKSTAF
//
